chr17-74748731-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_004252.5(NHERF1):​c.-116C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000694 in 926,672 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0029 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00026 ( 0 hom. )

Consequence

NHERF1
NM_004252.5 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.875

Publications

0 publications found
Variant links:
Genes affected
NHERF1 (HGNC:11075): (NHERF family PDZ scaffold protein 1) This gene encodes a sodium/hydrogen exchanger regulatory cofactor. The protein interacts with and regulates various proteins including the cystic fibrosis transmembrane conductance regulator and G-protein coupled receptors such as the beta2-adrenergic receptor and the parathyroid hormone 1 receptor. The protein also interacts with proteins that function as linkers between integral membrane and cytoskeletal proteins. The protein localizes to actin-rich structures including membrane ruffles, microvilli, and filopodia. Mutations in this gene result in hypophosphatemic nephrolithiasis/osteoporosis type 2, and loss of heterozygosity of this gene is implicated in breast cancer.[provided by RefSeq, Sep 2009]
SLC9A3R1-AS1 (HGNC:55322): (SLC9A3R1 antisense RNA 1)
MIR3615 (HGNC:38905): (microRNA 3615) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 17-74748731-C-T is Benign according to our data. Variant chr17-74748731-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2572959.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 445 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004252.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NHERF1
NM_004252.5
MANE Select
c.-116C>T
5_prime_UTR
Exon 1 of 6NP_004243.1O14745-1
SLC9A3R1-AS1
NR_187307.1
n.1002G>A
non_coding_transcript_exon
Exon 2 of 3
MIR3615
NR_037409.1
n.*32C>T
downstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NHERF1
ENST00000262613.10
TSL:1 MANE Select
c.-116C>T
5_prime_UTR
Exon 1 of 6ENSP00000262613.5O14745-1
NHERF1
ENST00000851804.1
c.-116C>T
5_prime_UTR
Exon 1 of 7ENSP00000521863.1
NHERF1
ENST00000851803.1
c.-116C>T
5_prime_UTR
Exon 1 of 6ENSP00000521862.1

Frequencies

GnomAD3 genomes
AF:
0.00289
AC:
439
AN:
152166
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00999
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000612
AC:
37
AN:
60460
AF XY:
0.000425
show subpopulations
Gnomad AFR exome
AF:
0.00939
Gnomad AMR exome
AF:
0.000355
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000494
GnomAD4 exome
AF:
0.000256
AC:
198
AN:
774390
Hom.:
0
Cov.:
10
AF XY:
0.000199
AC XY:
78
AN XY:
392218
show subpopulations
African (AFR)
AF:
0.00807
AC:
139
AN:
17220
American (AMR)
AF:
0.000829
AC:
17
AN:
20508
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16298
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31210
South Asian (SAS)
AF:
0.00
AC:
0
AN:
55042
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
30208
Middle Eastern (MID)
AF:
0.000463
AC:
2
AN:
4316
European-Non Finnish (NFE)
AF:
0.0000213
AC:
12
AN:
562730
Other (OTH)
AF:
0.000760
AC:
28
AN:
36858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00292
AC:
445
AN:
152282
Hom.:
4
Cov.:
33
AF XY:
0.00281
AC XY:
209
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0101
AC:
420
AN:
41568
American (AMR)
AF:
0.00131
AC:
20
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68008
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00219
Hom.:
0
Bravo
AF:
0.00342

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
7.2
DANN
Benign
0.87
PhyloP100
-0.88
PromoterAI
0.044
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs551803753; hg19: chr17-72744870; API